The surgical meshes market size has grown strongly in recent years. It will grow from $2.15 billion in 2025 to $2.28 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising incidence of hernia repair and pelvic organ prolapse surgeries, increasing adoption of mesh-based tissue reinforcement techniques, availability of synthetic polypropylene and polyester mesh products, expansion of hospital surgical capacity and general surgery procedures, growing emphasis on post-surgical structural stability and recurrence reduction.
The surgical meshes market size is expected to see strong growth in the next few years. It will grow to $2.91 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising demand for biologic and biosynthetic surgical mesh alternatives, increasing use of hybrid and composite mesh systems in complex reconstructions, growing procedure volumes in ambulatory surgical centers and outpatient settings, expanding utilization of absorbable and partially absorbable mesh designs, rising focus on patient outcomes safety profiles and long-term durability. Major trends in the forecast period include rising adoption of surgical meshes in hernia repair and pelvic organ prolapse procedures, increasing use of synthetic biologic and hybrid mesh materials for tissue reinforcement, growing preference for absorbable non-absorbable and partially absorbable mesh variants, expansion of surgical mesh utilization across traumatic wound repair and abdominal reconstruction, increasing deployment of surgical meshes across hospitals clinics and ambulatory surgical centers.
The growing number of surgical procedures is expected to drive the expansion of the surgical meshes market going forward. A surgical procedure refers to a medical treatment or intervention that uses invasive techniques to diagnose, treat, or manage a health condition or injury. As global populations continue to age, the incidence of age-related conditions requiring surgical intervention - such as joint replacements, cataract surgeries, and coronary bypass procedures - has increased. Surgical meshes play a critical role in surgical procedures by reinforcing weakened or damaged tissues, reducing the risk of hernia recurrence, supporting wound closure, enhancing tissue reconstruction, enabling minimally invasive approaches, and lowering the likelihood of complications such as adhesions. For example, in June 2023, according to the International Society of Aesthetic Plastic Surgery, a Switzerland-based professional organization, the total number of surgical and non-surgical aesthetic procedures worldwide increased to 34.9 million in 2023, compared with 33.7 million in 2022. Therefore, the rising volume of surgical procedures is contributing to the growth of the surgical meshes market.
Companies operating in the surgical meshes market are increasingly focused on developing advanced solutions, such as fully absorbable hernia patches, to broaden treatment options and reduce long-term complications associated with permanent implants. Fully absorbable hernia patches are manufactured using bioresorbable materials that provide temporary mechanical support during tissue healing and gradually degrade over time, thereby minimizing the risk of chronic foreign-body reactions and long-term mesh-related issues. For instance, in April 2025, Becton, Dickinson and Company, a US-based medical device company, announced FDA 510(k) clearance and the commercial launch of the Phasix ST Umbilical Hernia Patch, the first fully absorbable hernia patch specifically designed for umbilical hernia repair. The patch is made from poly-4-hydroxybutyrate (P4HB) and incorporates a Sepra hydrogel barrier. It features a pocket-and-strap design to simplify placement and fixation and can be implanted using the same surgical techniques as traditional permanent mesh patches, while offering a bioabsorbable alternative for tissue reinforcement.
In February 2024, RTI Surgical, a US-based contract development and manufacturing organization, completed the acquisition of Cook Biotech for an undisclosed amount. This acquisition is intended to strengthen RTI Surgical’s regenerative medicine and biomaterials capabilities by incorporating Cook Biotech’s porcine small intestinal submucosa (SIS) technology platform. The transaction expands RTI’s allograft and xenograft product portfolio and supports the scaling of comprehensive end-to-end services for soft-tissue repair applications. Cook Biotech is a US-based biotechnology company specializing in SIS-derived biomaterials and scaffold technologies used in hernia repair, soft-tissue reconstruction, and regenerative medicine.
Major companies operating in the surgical meshes market are Medtronic Plc, Boston Scientific Corporation, B Braun Melsungen AG, Ethicon Inc, W L Gore & Associates Inc, Mölnlycke Health Care AB, CR Bard Inc, LifeNet Health Inc, TELA Bio, LifeCell International Pvt Ltd, Lotus Surgicals Private Limited, Tepha Inc, Cousin Biotech SAS, Dipromed, Betatech Medical, Vitrex Medical A S, Pierson Surgical Ltd, Altaylar Medical, Bard Peripheral Vascular Inc, Surgenex Medical.
North America was the largest region in the surgical mesh market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical meshes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surgical meshes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the surgical meshes market by increasing import costs for polypropylene fibers, polyester materials, biologic tissue substrates, coatings, and sterilization components used in synthetic, biosynthetic, biologic, and hybrid mesh production, which raises manufacturing and procurement costs for hospitals, clinics, and ambulatory surgical centers. The impact is more pronounced in North America, Europe, and Asia-Pacific regions that depend on cross-border sourcing of medical textiles and biologic raw materials across absorbable, non-absorbable, and partially absorbable mesh categories. These higher landed costs have led to pricing pressures and slower purchasing cycles in cost-sensitive facilities; however, tariffs have also encouraged localized textile processing, regional contract manufacturing, and near-shoring initiatives, generating selective positive effects for domestic mesh producers.
The surgical meshes market research report is one of a series of new reports that provides surgical meshes market statistics, including surgical meshes industry global market size, regional shares, competitors with a surgical meshes market share, detailed surgical meshes market segments, market trends and opportunities, and any further data you may need to thrive in the surgical meshes industry. This surgical meshes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A surgical meshes are medical devices made of synthetic or biological materials that is used to provide additional support to weakened or damaged tissue. It is commonly used in the repair of pelvic organ prolapse and stress urinary incontinence in women, as well as in hernia repair surgery.
The main types of surgical meshes products are synthetic surgical meshes, biosynthetic surgical meshes, biologic surgical meshes, and hybrid or composite surgical meshes. Synthetic surgical meshes are medical devices made of synthetic materials used to provide additional support to weakened or damaged tissue during surgical procedures. These meshes are available various nature types such as absorbable surgical meshes, non-absorbable surgical meshes, and partially absorbable surgical meshes channeled through direct channel and in-direct channel. The various applications are hernia repair, traumatic or surgical wounds, abdominal wall reconstruction, and facial surgery used in hospitals, ambulatory surgical centers, clinics, and others.
The surgical mesh market consists of sales of macroporous meshes, microporous meshes and plaited polyester meshes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The surgical meshes market size is expected to see strong growth in the next few years. It will grow to $2.91 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising demand for biologic and biosynthetic surgical mesh alternatives, increasing use of hybrid and composite mesh systems in complex reconstructions, growing procedure volumes in ambulatory surgical centers and outpatient settings, expanding utilization of absorbable and partially absorbable mesh designs, rising focus on patient outcomes safety profiles and long-term durability. Major trends in the forecast period include rising adoption of surgical meshes in hernia repair and pelvic organ prolapse procedures, increasing use of synthetic biologic and hybrid mesh materials for tissue reinforcement, growing preference for absorbable non-absorbable and partially absorbable mesh variants, expansion of surgical mesh utilization across traumatic wound repair and abdominal reconstruction, increasing deployment of surgical meshes across hospitals clinics and ambulatory surgical centers.
The growing number of surgical procedures is expected to drive the expansion of the surgical meshes market going forward. A surgical procedure refers to a medical treatment or intervention that uses invasive techniques to diagnose, treat, or manage a health condition or injury. As global populations continue to age, the incidence of age-related conditions requiring surgical intervention - such as joint replacements, cataract surgeries, and coronary bypass procedures - has increased. Surgical meshes play a critical role in surgical procedures by reinforcing weakened or damaged tissues, reducing the risk of hernia recurrence, supporting wound closure, enhancing tissue reconstruction, enabling minimally invasive approaches, and lowering the likelihood of complications such as adhesions. For example, in June 2023, according to the International Society of Aesthetic Plastic Surgery, a Switzerland-based professional organization, the total number of surgical and non-surgical aesthetic procedures worldwide increased to 34.9 million in 2023, compared with 33.7 million in 2022. Therefore, the rising volume of surgical procedures is contributing to the growth of the surgical meshes market.
Companies operating in the surgical meshes market are increasingly focused on developing advanced solutions, such as fully absorbable hernia patches, to broaden treatment options and reduce long-term complications associated with permanent implants. Fully absorbable hernia patches are manufactured using bioresorbable materials that provide temporary mechanical support during tissue healing and gradually degrade over time, thereby minimizing the risk of chronic foreign-body reactions and long-term mesh-related issues. For instance, in April 2025, Becton, Dickinson and Company, a US-based medical device company, announced FDA 510(k) clearance and the commercial launch of the Phasix ST Umbilical Hernia Patch, the first fully absorbable hernia patch specifically designed for umbilical hernia repair. The patch is made from poly-4-hydroxybutyrate (P4HB) and incorporates a Sepra hydrogel barrier. It features a pocket-and-strap design to simplify placement and fixation and can be implanted using the same surgical techniques as traditional permanent mesh patches, while offering a bioabsorbable alternative for tissue reinforcement.
In February 2024, RTI Surgical, a US-based contract development and manufacturing organization, completed the acquisition of Cook Biotech for an undisclosed amount. This acquisition is intended to strengthen RTI Surgical’s regenerative medicine and biomaterials capabilities by incorporating Cook Biotech’s porcine small intestinal submucosa (SIS) technology platform. The transaction expands RTI’s allograft and xenograft product portfolio and supports the scaling of comprehensive end-to-end services for soft-tissue repair applications. Cook Biotech is a US-based biotechnology company specializing in SIS-derived biomaterials and scaffold technologies used in hernia repair, soft-tissue reconstruction, and regenerative medicine.
Major companies operating in the surgical meshes market are Medtronic Plc, Boston Scientific Corporation, B Braun Melsungen AG, Ethicon Inc, W L Gore & Associates Inc, Mölnlycke Health Care AB, CR Bard Inc, LifeNet Health Inc, TELA Bio, LifeCell International Pvt Ltd, Lotus Surgicals Private Limited, Tepha Inc, Cousin Biotech SAS, Dipromed, Betatech Medical, Vitrex Medical A S, Pierson Surgical Ltd, Altaylar Medical, Bard Peripheral Vascular Inc, Surgenex Medical.
North America was the largest region in the surgical mesh market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical meshes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surgical meshes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the surgical meshes market by increasing import costs for polypropylene fibers, polyester materials, biologic tissue substrates, coatings, and sterilization components used in synthetic, biosynthetic, biologic, and hybrid mesh production, which raises manufacturing and procurement costs for hospitals, clinics, and ambulatory surgical centers. The impact is more pronounced in North America, Europe, and Asia-Pacific regions that depend on cross-border sourcing of medical textiles and biologic raw materials across absorbable, non-absorbable, and partially absorbable mesh categories. These higher landed costs have led to pricing pressures and slower purchasing cycles in cost-sensitive facilities; however, tariffs have also encouraged localized textile processing, regional contract manufacturing, and near-shoring initiatives, generating selective positive effects for domestic mesh producers.
The surgical meshes market research report is one of a series of new reports that provides surgical meshes market statistics, including surgical meshes industry global market size, regional shares, competitors with a surgical meshes market share, detailed surgical meshes market segments, market trends and opportunities, and any further data you may need to thrive in the surgical meshes industry. This surgical meshes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A surgical meshes are medical devices made of synthetic or biological materials that is used to provide additional support to weakened or damaged tissue. It is commonly used in the repair of pelvic organ prolapse and stress urinary incontinence in women, as well as in hernia repair surgery.
The main types of surgical meshes products are synthetic surgical meshes, biosynthetic surgical meshes, biologic surgical meshes, and hybrid or composite surgical meshes. Synthetic surgical meshes are medical devices made of synthetic materials used to provide additional support to weakened or damaged tissue during surgical procedures. These meshes are available various nature types such as absorbable surgical meshes, non-absorbable surgical meshes, and partially absorbable surgical meshes channeled through direct channel and in-direct channel. The various applications are hernia repair, traumatic or surgical wounds, abdominal wall reconstruction, and facial surgery used in hospitals, ambulatory surgical centers, clinics, and others.
The surgical mesh market consists of sales of macroporous meshes, microporous meshes and plaited polyester meshes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Surgical Meshes Market Characteristics
3. Surgical Meshes Market Supply Chain Analysis
4. Global Surgical Meshes Market Trends and Strategies
5. Surgical Meshes Market Analysis of End Use Industries
7. Global Surgical Meshes Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Surgical Meshes Total Addressable Market (TAM) Analysis for the Market
9. Surgical Meshes Market Segmentation
10. Surgical Meshes Market Regional and Country Analysis
11. Asia-Pacific Surgical Meshes Market
12. China Surgical Meshes Market
13. India Surgical Meshes Market
14. Japan Surgical Meshes Market
15. Australia Surgical Meshes Market
16. Indonesia Surgical Meshes Market
17. South Korea Surgical Meshes Market
18. Taiwan Surgical Meshes Market
19. South East Asia Surgical Meshes Market
20. Western Europe Surgical Meshes Market
21. UK Surgical Meshes Market
22. Germany Surgical Meshes Market
23. France Surgical Meshes Market
24. Italy Surgical Meshes Market
25. Spain Surgical Meshes Market
26. Eastern Europe Surgical Meshes Market
27. Russia Surgical Meshes Market
28. North America Surgical Meshes Market
29. USA Surgical Meshes Market
30. Canada Surgical Meshes Market
31. South America Surgical Meshes Market
32. Brazil Surgical Meshes Market
33. Middle East Surgical Meshes Market
34. Africa Surgical Meshes Market
36. Surgical Meshes Market Competitive Landscape and Company Profiles
37. Surgical Meshes Market Other Major and Innovative Companies
40. Surgical Meshes Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Surgical Meshes Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses surgical meshes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for surgical meshes? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The surgical meshes market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Synthetic Surgical Meshes; Biosynthetic Surgical Meshes; Biologic Surgical Meshes; Hybrid Or Composite Surgical Meshes2) By Nature: Absorbable Surgical Meshes; Non-Absorbable Surgical Meshes; Partially Absorbable Surgical Meshes
3) By Sales Channel: Direct Channel; In-Direct Channel
4) By Application: Hernia Repair; Traumatic Or Surgical Wounds; Abdominal Wall Reconstruction; Facial Surgery
5) By End-User: Hospitals; Ambulatory Surgical Centers; Clinics; Other End-Users
Subsegments:
1) By Synthetic Surgical Meshes: Polypropylene Mesh; Polyester Mesh; Expanded Polytetrafluoroethylene (ePTFE) Mesh2) By Biosynthetic Surgical Meshes: Collagen-Based Mesh; Acellular Dermal Matrix
3) By Biologic Surgical Meshes: Human Tissue-Derived Mesh; Animal Tissue-Derived Mesh
4) By Hybrid Or Composite Surgical Meshes: Composite Mesh; Reinforced Mesh
Companies Mentioned: Medtronic Plc; Boston Scientific Corporation; B Braun Melsungen AG; Ethicon Inc; W L Gore & Associates Inc; Mölnlycke Health Care AB; CR Bard Inc; LifeNet Health Inc; TELA Bio; LifeCell International Pvt Ltd; Lotus Surgicals Private Limited; Tepha Inc; Cousin Biotech SAS; Dipromed; Betatech Medical; Vitrex Medical A S; Pierson Surgical Ltd; Altaylar Medical; Bard Peripheral Vascular Inc; Surgenex Medical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Surgical Meshes market report include:- Medtronic Plc
- Boston Scientific Corporation
- B Braun Melsungen AG
- Ethicon Inc
- W L Gore & Associates Inc
- Mölnlycke Health Care AB
- CR Bard Inc
- LifeNet Health Inc
- TELA Bio
- LifeCell International Pvt Ltd
- Lotus Surgicals Private Limited
- Tepha Inc
- Cousin Biotech SAS
- Dipromed
- Betatech Medical
- Vitrex Medical A S
- Pierson Surgical Ltd
- Altaylar Medical
- Bard Peripheral Vascular Inc
- Surgenex Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.28 Billion |
| Forecasted Market Value ( USD | $ 2.91 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
